Expression and clinical significance of stem cell marker CD133 in human neuroblastoma.
about
Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastomaValproic Acid Increases CD133 Positive Cells that Show Low Sensitivity to Cytostatics in NeuroblastomaAnalysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks.Intermittent hypoxia regulates stem-like characteristics and differentiation of neuroblastoma cells.Lung-residing metastatic and dormant neuroblastoma cells.Preliminary analysis of stem cell-like cells in human neuroblastoma.A distinct gene expression signature characterizes human neuroblastoma cancer stem cells.Efficient Killing of High Risk Neuroblastoma Using Natural Killer Cells Activated by Plasmacytoid Dendritic Cells.The role of CD133+ cells in a recurrent embryonal tumor with abundant neuropil and true rosettes (ETANTR).Characterization of GD3 ganglioside as a novel biomarker of mouse neural stem cells.CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges.CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway.Cancer Stem Cells and Pediatric Solid Tumors.Immunohistochemical detection of epithelialmesenchymal transition associated with stemness phenotype in anaplastic thyroid carcinoma.Improved therapy for neuroblastoma using a combination approach: superior efficacy with vismodegib and topotecanNeuroblastoma pathogenesis: deregulation of embryonic neural crest development.Clear cell sarcoma of kidney: morphoproteomic analysis reveals genomic correlates and therapeutic options.Expression of stem cell markers, CD133 and CD44, in pediatric solid tumors: a study using tissue microarray.Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma.PTEN status is related to cell proliferation and self-renewal independent of CD133 phenotype in the glioma-initiating cells.
P2860
Q26822652-83625C05-6CE7-4F92-9E32-2A1AB68CBE46Q28554068-62B4BEDC-A367-4686-8E1F-DFD1F7DFA8A7Q33718376-82C97FB7-D99A-41F3-A4B5-19C33A1228E4Q34170335-74C25325-BD43-47A9-906D-965013B077D6Q35070130-23AECF19-575A-4B92-B4D3-8211C8C92517Q35457604-3B56E9ED-666C-45C4-8A42-98204A7D602DQ36148130-6453E4D2-3132-49A8-BD35-B219CFD9C267Q36157777-1235347D-80CA-4BDB-946C-C0E3956970E0Q37402364-095E7015-9C5C-4A01-A5C6-F5408CA40F06Q37433814-01136DFA-64F4-48A1-BB74-466B9AAD6674Q38035206-93714A1A-B087-42A0-833C-EED17B72EA9EQ39384559-379446A0-6B0B-4C8F-8AE4-33874E44300CQ39773200-9F01252E-8257-444F-A01C-2383ACA12545Q39806508-C7E26DF7-D201-4861-9156-70191C32C8C1Q39954004-2A19BCE7-A708-401E-901E-D807554BE3AAQ45875651-AE123E16-F846-4297-B12E-B0915C5F754AQ46311312-75E542D2-4BAF-4DED-8916-3DA66D5DE8D2Q53126633-CEF7419A-0682-4931-A6BA-F97B5C2308B4Q54616742-FB3665BA-1F34-4017-91B6-1BA71F49BED1Q54630382-1B72FF2B-EA54-481B-890D-1F4225E4863C
P2860
Expression and clinical significance of stem cell marker CD133 in human neuroblastoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Expression and clinical significance of stem cell marker CD133 in human neuroblastoma.
@en
Expression and clinical significance of stem cell marker CD133 in human neuroblastoma.
@nl
type
label
Expression and clinical significance of stem cell marker CD133 in human neuroblastoma.
@en
Expression and clinical significance of stem cell marker CD133 in human neuroblastoma.
@nl
prefLabel
Expression and clinical significance of stem cell marker CD133 in human neuroblastoma.
@en
Expression and clinical significance of stem cell marker CD133 in human neuroblastoma.
@nl
P2093
P1476
Expression and clinical significance of stem cell marker CD133 in human neuroblastoma.
@en
P2093
Guo-Song Jiang
Jia-Bin Cai
Li-Duan Zheng
Qiang-Song Tong
Qing-Lan Ruan
Shao-Tao Tang
Shi-Wang Li
P2888
P356
10.1007/S12519-008-0012-Z
P577
2008-02-01T00:00:00Z